{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:39:53Z","timestamp":1771501193031,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychoneuroendocrinology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.psyneuen.2015.12.001","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T08:05:47Z","timestamp":1449216347000},"page":"15-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"special_numbering":"C","title":["Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer\u2019s disease and type 2 diabetes"],"prefix":"10.1016","volume":"65","author":[{"given":"Carmen","family":"Infante-Garcia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jose","family":"Ramos-Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Galindo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Garcia-Alloza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psyneuen.2015.12.001_bib0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/archneur.61.5.661","article-title":"Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function","volume":"61","author":"Arvanitakis","year":"2004","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0010","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/db14-0348","article-title":"Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?","volume":"63","author":"Biessels","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0015","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/j.euroneuro.2014.01.023","article-title":"Brain imaging in type 2 diabetes","volume":"24","author":"Brundel","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0020","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.psyneuen.2010.06.009","article-title":"Effects of intensified metabolic control on CNS function in type 2 diabetes","volume":"36","author":"Cooray","year":"2011","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0025","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.arr.2011.01.001","article-title":"Insulin-resistant brain state: the culprit in sporadic Alzheimer\u2019s disease?","volume":"10","author":"Correia","year":"2011","journal-title":"Age. Res. Rev."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0030","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1001\/archneurol.2009.27","article-title":"The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged","volume":"66","author":"Craft","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0035","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S0306-4530(02)00087-2","article-title":"Insulin dose-response effects on memory and plasma amyloid precursor protein in Alzheimer\u2019s disease: interactions with apolipoprotein E genotype","volume":"28","author":"Craft","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0040","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.2337\/db13-1954","article-title":"Inflammation, defective insulin signaling, and mitochondrial dysfunction as common molecular denominators connecting type 2 diabetes to Alzheimer disease","volume":"63","author":"De Felice","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0045","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1007\/s00125-003-1235-0","article-title":"Type 2 diabetes and atrophy of medial temporal lobe structures on brain MRI","volume":"46","author":"den Heijer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0050","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainresprot.2005.08.001","article-title":"Episodic-like memory in mice: simultaneous assessment of object, place and temporal order memory","volume":"16","author":"Dere","year":"2005","journal-title":"Brain Res. Brain Res. Protoc."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0055","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jneuroim.2014.01.013","article-title":"Glucocorticoid sensitization of microglia in a genetic mouse model of obesity and diabetes","volume":"269","author":"Dey","year":"2014","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0060","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.peptides.2005.10.006","article-title":"Effects of leptin on memory processing","volume":"27","author":"Farr","year":"2006","journal-title":"Peptides"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0065","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1073\/pnas.0230450100","article-title":"Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo","volume":"100","author":"Farris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0070","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1097\/01.jnen.0000240468.12543.af","article-title":"Plaque-derived oxidative stress mediates distorted neurite trajectories in the Alzheimer mouse model","volume":"65","author":"Garcia-Alloza","year":"2006","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0075","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1471-4159.2007.04613.x","article-title":"Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model","volume":"102","author":"Garcia-Alloza","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0080","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.nbd.2007.07.019","article-title":"A limited role for microglia in antibody mediated plaque clearance in APP mice","volume":"28","author":"Garcia-Alloza","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0085","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1093\/brain\/awr300","article-title":"Cerebrovascular lesions induce transient beta-amyloid deposition","volume":"134","author":"Garcia-Alloza","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0090","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/jne.12138","article-title":"Protective effect of leptin and ghrelin against toxicity induced by amyloid-beta oligomers in a hypothalamic cell line","volume":"26","author":"Gomes","year":"2014","journal-title":"J. Neuroendocrinol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0095","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00018-009-9070-1","article-title":"Common features between diabetes mellitus and Alzheimer\u2019s disease","volume":"66","author":"Gotz","year":"2009","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0100","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1373\/clinchem.2010.144006","article-title":"Leptin: the missing link in Alzheimer disease?","volume":"56","author":"Harvey","year":"2010","journal-title":"Clin. Chem."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0105","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer\u2019s disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0110","doi-asserted-by":"crossref","first-page":"4371","DOI":"10.1111\/febs.12250","article-title":"Regulatable transgenic mouse models of Alzheimer disease: onset, reversibility and spreading of tau pathology","volume":"280","author":"Hochgrafe","year":"2013","journal-title":"FEBS J."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0115","doi-asserted-by":"crossref","first-page":"T31","DOI":"10.1530\/JOE-13-0221","article-title":"Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases","volume":"221","author":"Holscher","year":"2014","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0120","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jalz.2013.12.009","article-title":"The incretin hormones glucagonlike peptide 1 and glucose-dependent insulinotropic polypeptide are neuroprotective in mouse models of Alzheimer\u2019s disease","volume":"10","author":"Holscher","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0125","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.neurobiolaging.2003.09.008","article-title":"APP processing and amyloid deposition in mice haplo-insufficient for presenilin 1","volume":"25","author":"Jankowsky","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0130","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1152\/ajpendo.00500.2011","article-title":"Increased Abeta production prompts the onset of glucose intolerance and insulin resistance","volume":"11","author":"Jimenez-Palomares","year":"2012","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0135","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1210\/en.2009-0695","article-title":"Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes","volume":"150","author":"Kim","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0140","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","article-title":"Insulin resistance in the nervous system","volume":"23","author":"Kim","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0145","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/archneur.64.4.570","article-title":"Relation of diabetes to mild cognitive impairment","volume":"64","author":"Luchsinger","year":"2007","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0150","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1038\/nature06616","article-title":"Rapid appearance and local toxicity of amyloid-beta plaques in a mouse model of Alzheimer\u2019s disease","volume":"451","author":"Meyer-Luehmann","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0155","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1161\/STROKEAHA.114.006078","article-title":"Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice","volume":"45","author":"Milner","year":"2014","journal-title":"Stroke"},{"issue":"12","key":"10.1016\/j.psyneuen.2015.12.001_bib0160","doi-asserted-by":"crossref","first-page":"4036","DOI":"10.2337\/dc13-0143","article-title":"Brain atrophy in type 2 diabetes: regional distribution and influence on cognition","volume":"36","author":"Moran","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0165","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuint.2006.03.017","article-title":"Modulation of microglial activation state following passive immunization in amyloid depositing transgenic mice","volume":"49","author":"Morgan","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0170","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/2051-5960-2-64","article-title":"Obesity and diabetes cause cognitive dysfunction in the absence of accelerated beta-amyloid deposition in a novel murine model of mixed or vascular dementia","volume":"2","author":"Niedowicz","year":"2014","journal-title":"Acta Neuropathol. Commun. ."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0175","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1007\/s001250050588","article-title":"Association of diabetes mellitus and dementia: the Rotterdam study","volume":"39","author":"Ott","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0180","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.nbd.2007.06.015","article-title":"Cholinergic forebrain degeneration in the APPswe\/PS1DeltaE9 transgenic mouse","volume":"28","author":"Perez","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0185","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2009.09.022","article-title":"Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2","volume":"288","author":"Plastino","year":"2010","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0190","article-title":"Increased spontaneous central bleeding and cognition impairment in APP\/PS1 mice with poorly controlled diabetes mellitus","volume":"9","author":"Ramos-Rodriguez","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0195","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.psyneuen.2015.07.606","article-title":"Central vascular disease and exacerbated pathology in a mixed model of type 2 diabetes and Alzheimer\u2019s disease","volume":"62","author":"Ramos-Rodriguez","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0200","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.psyneuen.2014.06.005","article-title":"Prediabetes-induced vascular alterations exacerbate central pathology in APPswe\/PS1dE9 mice","volume":"48","author":"Ramos-Rodriguez","year":"2014","journal-title":"Psychoneuroendocrinology"},{"issue":"11","key":"10.1016\/j.psyneuen.2015.12.001_bib0205","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.psyneuen.2013.05.010","article-title":"Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice","volume":"38","author":"Ramos-Rodriguez","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0210","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.psyneuen.2013.05.010","article-title":"Differential central pathology and cognitive impairment in pre-diabetic and diabetic mice","volume":"38","author":"Ramos-Rodriguez","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0215","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/NEN.0b013e318288a8dd","article-title":"Rapid beta-amyloid deposition and cognitive impairment after cholinergic denervation in APP\/PS1 mice","volume":"72","author":"Ramos-Rodriguez","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0220","doi-asserted-by":"crossref","first-page":"a006189","DOI":"10.1101\/cshperspect.a006189","article-title":"Neuropathological alterations in Alzheimer disease","volume":"1","author":"Serrano-Pozo","year":"2011","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0225","doi-asserted-by":"crossref","first-page":"7278","DOI":"10.1523\/JNEUROSCI.1879-05.2005","article-title":"Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy","volume":"25","author":"Spires","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0230","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1750-1326-9-30","article-title":"Neuroinflammation and neurologic deficits in diabetes linked to brain accumulation of amylin","volume":"9","author":"Srodulski","year":"2014","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0235","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1523\/JNEUROSCI.0462-04.2004","article-title":"Cortical synaptic integration in vivo is disrupted by amyloid-beta plaques","volume":"24","author":"Stern","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0240","doi-asserted-by":"crossref","first-page":"7036","DOI":"10.1073\/pnas.1000645107","article-title":"Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetes","volume":"107","author":"Takeda","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0245","doi-asserted-by":"crossref","first-page":"e82991","DOI":"10.1371\/journal.pone.0082991","article-title":"The interaction of age and type 2 diabetes on executive function and memory in persons aged 35 years or older","volume":"8","author":"van Eersel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0250","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.neuron.2004.09.010","article-title":"Deciphering the molecular basis of memory failure in Alzheimer\u2019s disease","volume":"44","author":"Walsh","year":"2004","journal-title":"Neuron"},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0260","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.psyneuen.2015.12.001_bib0265","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1093\/brain\/awt210","article-title":"Inflammatory components in human Alzheimer\u2019s disease and after active amyloid-beta42 immunization","volume":"136","author":"Zotova","year":"2013","journal-title":"Brain"}],"container-title":["Psychoneuroendocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015300238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306453015300238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T16:50:54Z","timestamp":1759683054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306453015300238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":53,"alternative-id":["S0306453015300238"],"URL":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.12.001","relation":{},"ISSN":["0306-4530"],"issn-type":[{"value":"0306-4530","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer\u2019s disease and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"Psychoneuroendocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psyneuen.2015.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}